Cuatrecasas advises Comercial Rafer on joining Palex Medical

Cuatrecasas advised the Zaragoza-headquartered company Comercial Rafer on its incorporation in hospital equipment supplier Palex Medical, one of the Palex Group companies owned by private equity funds Ergon Capital and Corpfin Capital.

The purchase agreement was signed in January, with Palex incorporating histocompatibility testing related to organ transplants and other strategic products in its In Vitro Diagnostics and Laboratory area.

The Cuatrecasas advisory team for this transaction was led by counsel Angel Modrego and made up of lawyers Ignacio Liria, María Isabel Roy, Cristian Calvo and Eva Pérez, the two latter supervised by partner Javier Garanto.

Palex—a major business group with over 65 years’ history and a leader in delivering advanced solutions in health-care, laboratory and industrial materials—has increased its number of specialties and consolidates its position as a state-of-the-art company in the area of in vitro diagnostic reagents in Spain and Portugal.

Rafer specializes in marketing laboratory reagents and instruments for different areas of clinical diagnosis, industry and research. It has a broad portfolio of products and services, both from external suppliers and its own developments.